NCT02137902

Brief Summary

This study aims to identify effective and cost-effective interventions for tobacco use and other risk behaviors for cardiovascular disease among Alaska Native people in rural villages. In a randomized controlled trial, the study will compare interventions using telemedicine to promote the American Heart Association's identified ideal health behaviors (nonsmoking and physical activity) relative to ideal health factors (managing cholesterol and blood pressure).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
299

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 14, 2014

Completed
1 year until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

February 14, 2022

Status Verified

January 1, 2022

Enrollment Period

4.8 years

First QC Date

May 12, 2014

Last Update Submit

January 28, 2022

Conditions

Keywords

Tobacco dependenceCardiovascular diseaseRisk behaviorsSmokingPhysical activityAlaska Native people

Outcome Measures

Primary Outcomes (1)

  • Smoking Status: 7-day point prevalence abstinence

    Change from baseline as no tobacco use, including a puff, in the past 7 days

    Assessed at baseline, 3, 6, 12, and 18 months

Secondary Outcomes (9)

  • Minutes of moderate-to-vigorous physical activity in past 7 days

    Assessed at baseline, 3, 6, 12, and 18 months

  • Blood pressure

    Assessed at baseline, 3, 6, 12, and 18 months

  • Total, LDL, and HDL cholesterol

    Assessed at baseline and 18 months

  • Body Mass Index (BMI)

    Assessed at baseline, 3, 6, 12, and 18 months

  • Framingham Risk Factor Score

    Assessed at baseline and 18 months

  • +4 more secondary outcomes

Study Arms (2)

Tobacco/Physical Activity Intervention

EXPERIMENTAL

Includes a psychosocial component that utilizes a counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for tobacco and physical activity, adherence with nicotine replacement therapy, and self-monitoring with a pedometer-based walking program. The intervention will provide 12 weeks of nicotine replacement therapy for participants.

Behavioral: Tobacco/Physical Activity Intervention

Diet plus BP/CHOL Intervention

EXPERIMENTAL

Consists of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for managing hypertension and hypercholesterolemia, and adherence with antihypertensives and statins with supportive dietary changes. The intervention provides a cookbook of heart healthy regional recipes and medication bag for storing medications.

Behavioral: Diet plus BP/CHOL Intervention

Interventions

Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation and goal setting for tobacco and physical activity, adherence with nicotine replacement therapy (NRT, patch plus gum or lozenge), and self-monitoring with a pedometer-based walking program.

Tobacco/Physical Activity Intervention

Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation, goal setting for managing HTN and HCL, and adherence with antihypertensives and statins with supportive dietary changes. Includes a native diet cookbook and medication bag.

Diet plus BP/CHOL Intervention

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Smoking \> 5 cigarettes/day and \> 100 cigarettes in one's lifetime
  • Hypertension, hypercholesterolemia, or established vascular disease
  • Fluent in English language

You may not qualify if:

  • Dementia or other brain injury
  • Pregnancy or breastfeeding
  • Currently engaged in tobacco treatment or using cessation pharmacotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Norton Sound Health Corporation

Nome, Alaska, 99762, United States

Location

Stanford Hospital and Clinics

Stanford, California, 94304, United States

Location

Related Publications (3)

  • Prochaska JJ, Benowitz NL. The Past, Present, and Future of Nicotine Addiction Therapy. Annu Rev Med. 2016;67:467-86. doi: 10.1146/annurev-med-111314-033712. Epub 2015 Aug 26.

    PMID: 26332005BACKGROUND
  • Prochaska JJ, Benowitz NL. Smoking cessation and the cardiovascular patient. Curr Opin Cardiol. 2015 Sep;30(5):506-11. doi: 10.1097/HCO.0000000000000204.

    PMID: 26196657BACKGROUND
  • Prochaska JJ, Epperson A, Skan J, Oppezzo M, Barnett P, Delucchi K, Schnellbaecher M, Benowitz NL. The Healing and Empowering Alaskan Lives Toward Healthy-Hearts (HEALTHH) Project: Study protocol for a randomized controlled trial of an intervention for tobacco use and other cardiovascular risk behaviors for Alaska Native People. Contemp Clin Trials. 2018 Aug;71:40-46. doi: 10.1016/j.cct.2018.06.003. Epub 2018 Jun 2.

MeSH Terms

Conditions

Tobacco Use DisorderCardiovascular DiseasesRisk-TakingSmokingMotor Activity

Interventions

Tobacco ProductsDiet

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Smoking DevicesManufactured MaterialsTechnology, Industry, and AgricultureNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Judith J Prochaska, PhD, MPH

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 12, 2014

First Posted

May 14, 2014

Study Start

June 1, 2015

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

February 14, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations